YONGIN, South Korea, May 30, 2025 /PRNewswire/ -- GC Biopharma, a South Korean pharmaceutical company, announced that the Phase 3 clinical trial results for Hunterase (idursulfase beta), its investigational drug for Hunter Syndrome (MPS II), have been published in Genetics in Medicine, an...
Read More Details
Finally We wish PressBee provided you with enough information of ( GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal )
Also on site :